China’s CDE grants breakthrough status approval to Abbisko’s HCC therapy
The CDE’s decision is supported by encouraging data from the Phase I trial.
Clinical Trials
Seres’ SER-155 gains breakthrough status for BSIs reduction
CPI’s Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System
Does Southeast Asia have a growing role in vaccine development?
AlloVir and Kalaris enter merger to advance retinal disease therapies
Invenra’s antibody gains US FDA designations for neuroblastoma treatment
Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials
Daiichi Sankyo-AstraZeneca’s ENHERTU gains BTD for breast cancer
